Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer

por Verhoek, Andre, Cheema, Parneet, Melosky, Barbara, Samson, Benoit, Shepherd, Frances A., de Marinis, Filippo, John, Thomas, Wu, Yi-Long, Heeg, Bart, Van Dalfsen, Nadia, Bracke, Benjamin, Miranda, Miguel, Shaw, Simon, Moldaver, Daniel
Publicado 2023